Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.050 | 100.050 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.635 | 19.980 |
Price to Book | 3.631 | 3.696 |
Price to Sales | 2.176 | 2.456 |
Price to Cash Flow | 12.654 | 13.651 |
Dividend Yield | 1.783 | 1.590 |
5 Years Earnings Growth | 11.115 | 11.669 |
Name | Net % | Category Average |
---|---|---|
Technology | 31.040 | 28.025 |
Healthcare | 13.550 | 13.525 |
Financial Services | 12.000 | 14.031 |
Consumer Cyclical | 11.870 | 10.610 |
Communication Services | 8.730 | 8.601 |
Industrials | 6.440 | 8.915 |
Consumer Defensive | 6.340 | 5.930 |
Energy | 4.130 | 4.198 |
Real Estate | 2.300 | 2.418 |
Basic Materials | 2.100 | 3.022 |
Utilities | 1.500 | 2.439 |
Number of long holdings: 318
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.51 | 430.32 | +0.04% | |
Apple | US0378331005 | 9.49 | 189.99 | +0.01% | |
Amazon.com | US0231351067 | 4.57 | 182.15 | +0.77% | |
NVIDIA | US67066G1040 | 3.86 | 1,139.01 | +6.98% | |
Alphabet A | US02079K3059 | 2.80 | 176.40 | +0.81% | |
Alphabet C | US02079K1079 | 2.41 | 178.02 | +0.96% | |
Tesla | US88160R1014 | 2.07 | 176.75 | -1.39% | |
UnitedHealth | US91324P1021 | 1.86 | 503.61 | -0.90% | |
Eli Lilly | US5324571083 | 1.71 | 807.85 | +0.05% | |
JPMorgan | US46625H1005 | 1.51 | 199.50 | -0.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BMTD2G30 | 934.9M | 16.28 | 16.56 | - | ||
IE00BMTD2Q38 | 141.51M | 9.46 | -2.28 | - | ||
IE00BMTD2L82 | 197.01M | 10.52 | - | - | ||
IE00BNNLSK63 | 449.96M | 37.98 | - | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review